abstract |
The present invention provides a method of increasing survival or progression-free survival in a patient with a solid tumor having an elevated serum concentration of C-reactive protein (CRP) by administering a JAK inhibitor or an IL-6 signal transduction inhibitor to the patient, Lt; RTI ID = 0.0 > survival < / RTI > in the patient. |